联合国贸易发展委员会-为投资非洲当地制药生产建立案例(英)

© Adobe StockUNI T E D NAT I O NS CO NFE R E N C E ON T R A D E A N D D E VE L OP M E N TPolicy reviewBuilding the case for investment in local pharmaceutical production in AfricaA comprehensive framework for investment policymakersGeneva, 2025ii@ 2025, United Nations All rights reserved worldwideRequests to reproduce excerpts or to photocopy should be addressed to the Copyright Clearance Center at copyright.com.All other queries on rights and licenses, including subsidiary rights, should be addressed to:United Nations Publications405 East 42nd StreetNew York, New York 10017United States of AmericaEmail: publications@un.orgWebsite: https.//shop.un.org/The findings, interpretations and conclusions expressed herein are those of the authors and do not necessarily reflect the views of the United Nations or its officials or Member States.The designations employed and the presentation of material on any map in this work do not imply the expression of any opinion whatsoever on the part of the United Nations concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.This publication has been edited externally.United Nations publication issued by the United Nations Conference on Trade and DevelopmentUNCTAD/DIAE/2024/5ISBN: 978-92-1-003454-8 eISBN: 978-92-1-107124-5 Sales No. E.25.II.D.22Building the case for investment in local pharmaceutical production in Africa A comprehensive framework for investment policymakersiiiAcknowledgementsThis report was prepared by a team at UNCTAD led by Bruno Casella under the guidance of Richard Bolwijn and the overall direction of Nan Li, Director of the Investment and Enterprise Division at UNCTAD.The report benefited from advice, comments and inputs provided by Kiyoshi Adachi, Ermias Biadgleng, Stephania Bonilla, Julien Bornon, Hamed El-Kady, Simona Marinescu, Massimo Meloni, Ian Richards , Amelia Santos-Paulino, Astrit Sulstarova and Arlette Verploegh at UNCTAD Division on Investment and Enterprise. The team also received valuable feedback from UNCTAD colleagues from other divisions, including Stephanie Garry and Anida Yupari Aguado. Research assistance was provided by Prachi Sharma.UNCTAD gratefully acknowledges the extensive contributions of Rory Horner (University of Manchester), as well as the helpful comments and feedback provided by Geoffrey Banda (University of Edinburgh), Nazeem Mohammed (international pharmaceutical consultant), Andrés Rodríguez-Pose (London School of Economics), Wesley Ronoh (Africa CDC) and Alastair West (international pharmaceutical consultant).UNCTAD extends its appreciation to Jicui Dong, Head of the Local Production and Assistance Unit at the World Health Organization, for valuable discussions, including in the context of the World Local Production Forum 2023 in The Hague and of the UNCTAD World Investment Forum 2023 in Abu Dhabi.The report was enriched by in-depth discussions held duri

立即下载
综合
2025-04-21
78页
8.79M
收藏
分享

联合国贸易发展委员会-为投资非洲当地制药生产建立案例(英),点击即可下载。报告格式为PDF,大小8.79M,页数78页,欢迎下载。

本报告共78页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共78页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
图 17. 2019-2023 年反贪污腐败管理体系与制度行业披露率
综合
2025-04-21
来源:医疗保健行业ESG管理策略研究报告-北京ESG研究院
查看原文
图 16. 2023 年研发员工占比行业中位数及披露率
综合
2025-04-21
来源:医疗保健行业ESG管理策略研究报告-北京ESG研究院
查看原文
图 15. 2019-2023 年研发与创新管理体系与制度行业披露率
综合
2025-04-21
来源:医疗保健行业ESG管理策略研究报告-北京ESG研究院
查看原文
图 14. 2019-2023 年产品召回程序行业披露率
综合
2025-04-21
来源:医疗保健行业ESG管理策略研究报告-北京ESG研究院
查看原文
图 13. 2019-2023 年产品质量管理体系与制度行业披露率
综合
2025-04-21
来源:医疗保健行业ESG管理策略研究报告-北京ESG研究院
查看原文
图 12. 2023 年每百万营收产生的有害废弃物总量(中位数)行业中位数及披露率
综合
2025-04-21
来源:医疗保健行业ESG管理策略研究报告-北京ESG研究院
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起